A Randomized Controlled, Open, Single-center Clinical Study Evaluating the Efficacy and Safety of Umbilical Cord Blood Mononuclear Cells in Patients with Refractory Immune Effector Cell-related Hemocytopenia
Conditions
- Refractory Immune Effector Cell-related Hemocytopenia
Interventions
- BIOLOGICAL: Umbilical cord blood mononuclear cells
- COMBINATION_PRODUCT: Conventional hematopoietic recovery therapy
Sponsor
Beijing GoBroad Hospital